867 Stoklara Genel Bakış
Bir yatırım holding şirketi olan China Medical System Holdings Limited, Çin Halk Cumhuriyeti'nde farmasötik ürünler üretmekte, satmakta, pazarlamakta ve tanıtmaktadır.
Kar Tanesi Skoru | |
---|---|
Değerleme | 4/6 |
Gelecekteki Büyüme | 4/6 |
Geçmiş Performans | 2/6 |
Finansal Sağlık | 6/6 |
Temettüler | 4/6 |
China Medical System Holdings Limited Rakipler
Fiyat Geçmişi ve Performans
Tarihsel hisse senedi fiyatları | |
---|---|
Güncel Hisse Fiyatı | HK$7.93 |
52 Haftanın En Yüksek Seviyesi | HK$15.86 |
52 Haftanın En Düşük Seviyesi | HK$6.23 |
Beta | 0.92 |
11 Aylık Değişim | -20.86% |
3 Aylık Değişim | 18.36% |
1 Yıllık Değişim | -41.69% |
33 Yıllık Değişim | -38.43% |
5 Yıllık Değişim | -34.25% |
Halka arzdan bu yana değişim | 163.63% |
Son Haberler & Güncellemeler
Recent updates
Earnings Tell The Story For China Medical System Holdings Limited (HKG:867) As Its Stock Soars 26%
Sep 30Little Excitement Around China Medical System Holdings Limited's (HKG:867) Earnings
Jul 15An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 20% Undervalued
May 22China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year
May 03We Think Shareholders May Want To Consider A Review Of China Medical System Holdings Limited's (HKG:867) CEO Compensation Package
May 02China Medical System Holdings' (HKG:867) Shareholders Will Receive A Smaller Dividend Than Last Year
Apr 19China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year
Mar 29Not Many Are Piling Into China Medical System Holdings Limited (HKG:867) Stock Yet As It Plummets 35%
Mar 28China Medical System Holdings Limited's (HKG:867) Share Price Not Quite Adding Up
Dec 21Is China Medical System Holdings (HKG:867) A Risky Investment?
Dec 04If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity
Nov 15China Medical System Holdings (HKG:867) Will Pay A Larger Dividend Than Last Year At CN¥0.342
Aug 31China Medical System Holdings (HKG:867) Could Easily Take On More Debt
Aug 30Here's Why We Think China Medical System Holdings (HKG:867) Might Deserve Your Attention Today
Aug 07We Think China Medical System Holdings (HKG:867) Can Manage Its Debt With Ease
May 14Does China Medical System Holdings (HKG:867) Deserve A Spot On Your Watchlist?
Apr 26An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 47% Undervalued
Feb 05China Medical System Holdings (HKG:867) Seems To Use Debt Rather Sparingly
Dec 26If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity
Dec 08Is China Medical System Holdings (HKG:867) Using Too Much Debt?
Sep 14China Medical System Holdings (HKG:867) Is Paying Out A Larger Dividend Than Last Year
Aug 25Do China Medical System Holdings' (HKG:867) Earnings Warrant Your Attention?
Aug 15An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 49% Undervalued
Jul 08Should You Be Adding China Medical System Holdings (HKG:867) To Your Watchlist Today?
May 16Does China Medical System Holdings (HKG:867) Have A Healthy Balance Sheet?
Apr 10China Medical System Holdings (HKG:867) Is Increasing Its Dividend To HK$0.28
Mar 22If You Like EPS Growth Then Check Out China Medical System Holdings (HKG:867) Before It's Too Late
Feb 09Does China Medical System Holdings (HKG:867) Have A Healthy Balance Sheet?
Dec 25Should You Be Adding China Medical System Holdings (HKG:867) To Your Watchlist Today?
Nov 10China Medical System Holdings (HKG:867) Could Easily Take On More Debt
Sep 25China Medical System Holdings' (HKG:867) Dividend Will Be Increased To HK$0.32
Aug 26Here's Why We Think China Medical System Holdings (HKG:867) Is Well Worth Watching
Jul 30An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 33% Undervalued
Jun 27China Medical System Holdings (HKG:867) Could Easily Take On More Debt
Jun 14Hissedar Getirileri
867 | HK Pharmaceuticals | HK Pazar | |
---|---|---|---|
7D | -4.6% | -7.2% | -1.0% |
1Y | -41.7% | -2.9% | 15.0% |
Getiri vs. Endüstri: 867 underperformed the Hong Kong Pharmaceuticals industry which returned -2.9% over the past year.
Getiri vs Piyasa: 867 underperformed the Hong Kong Market which returned 15% over the past year.
Fiyat Oynaklığı
867 volatility | |
---|---|
867 Average Weekly Movement | 6.6% |
Pharmaceuticals Industry Average Movement | 6.9% |
Market Average Movement | 9.0% |
10% most volatile stocks in HK Market | 19.0% |
10% least volatile stocks in HK Market | 4.3% |
İstikrarlı Hisse Senedi Fiyatı: 867 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Zaman İçindeki Volatilite: 867's weekly volatility (7%) has been stable over the past year.
Şirket Hakkında
Kuruldu | Çalışanlar | CEO | Web sitesi |
---|---|---|---|
1995 | 5,781 | Kong Lam | web.cms.net.cn/zh/home/ |
Bir yatırım holding şirketi olan China Medical System Holdings Limited, Çin Halk Cumhuriyeti'nde farmasötik ürünler üretmekte, satmakta, pazarlamakta ve tanıtmaktadır. Ürünleri arasında nöbet kümelerini tedavi etmek için bir diazepam burun spreyi olan VALTOCO; hipertansiyon ve stabil anjina pektoris tedavisi için Plendil; akut kalp yetmezliğini tedavi etmek için XinHuoSu; hafif ila orta dereceli depresyon, anksiyete ve psikosomatik etkiler için Deanxit bulunmaktadır; metotreksat enjeksiyonu olan METOJECT; ve safra kesesinde kolesterol safra taşları, kolestatik karaciğer hastalığı ve safra reflü gastriti tedavisi için Ursofalk. Şirket ayrıca Ülseratif Kolit ve Crohn hastalığının tedavisi için Salofalk; diyare tedavisi için Bioflor; dispepsi için Combizym; orta-şiddetli plak sedef hastalığını tedavi etmek için bir tildrakizumab enjeksiyonu olan ILUMETRI; senil makula dejenerasyonu ve astenopi tedavisi için Augentropfen Stulln Mono göz damlası ve hematomlu veya hematomsuz künt travmalar ve yüzeysel flebit için Hirudoid sunmaktadır.
China Medical System Holdings Limited Temel Bilgiler Özeti
867 temel i̇stati̇sti̇kler | |
---|---|
Piyasa değeri | HK$19.16b |
Kazançlar(TTM) | HK$1.52b |
Gelir(TTM) | HK$7.69b |
12.6x
F/K Oranı2.5x
P/S Oranı867 aşırı değerli mi?
Gerçeğe Uygun Değer ve değerleme analizine bakınızKazanç ve Gelir
867 gelir tablosu (TTM) | |
---|---|
Gelir | CN¥7.01b |
Gelir Maliyeti | CN¥1.85b |
Brüt Kâr | CN¥5.17b |
Diğer Giderler | CN¥3.78b |
Kazançlar | CN¥1.39b |
Son Raporlanan Kazançlar
Jun 30, 2024
Sonraki Kazanç Tarihi
n/a
Hisse başına kazanç (EPS) | 0.58 |
Brüt Marj | 73.66% |
Net Kâr Marjı | 19.82% |
Borç/Özkaynak Oranı | 6.9% |
867 uzun vadede nasıl bir performans gösterdi?
Geçmiş performansı ve karşılaştırmayı görün